Skip to content

Thromboelastography-Guided Fluid Management in Spinal Surgery

Thromboelastography-guided Fluid Management in Spinal Surgery: A Prospective Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03999086
Enrollment
50
Registered
2019-06-26
Start date
2018-01-12
Completion date
2019-11-08
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Fusion

Brief summary

The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.

Detailed description

Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.

Interventions

PROCEDUREIntervention

We will utilize thromboelastography to discern when to transfuse blood products in the setting of multi-level spinal fusion

OTHERControl Group

Laboratory analysis to guide transfusion

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* all patients undergoing elective multi-level spinal fusion for sagittal malalignment, multi-level spondylolisthesis, multi-level lumbar spinal stenosis, and adult degenerative scoliosis with ages between 18-89

Exclusion criteria

* patients with tumors, infection, or trauma

Design outcomes

Primary

MeasureTime frameDescription
Estimated Blood Losspost operative approximately 1 dayAmount of blood loss measured in units of cc(mL)
Volume of transfused packed red blood cellspost operative approximately 1 dayAmount of transfused packed red blood cells measured in units of cc(mL)
Adverse EventsOne yearNumber of adverse events reported

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026